Notice of Removal: Photoacoustic-ultrasonic imaging biomarkers for treatment-response assessment of sorafenib in a rat model of hepatocellular carcinoma

Houra Taghavi, Nina Munoz, Mohamed Naser, Kiersten Maldonado, Charles Kingsley, Yugi Tang, Katherine Dextraze, Rony Avritscher, Richard Bouchard

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Sorafenib is the only clinically approved drug for hepatocellular carcinoma (HCC), but its response rate is relatively poor. Recently, it has been shown that tissue hypoxia and perfusion have predictive correlation with HCC response to sorafenib treatment. In this study, we investigate the correlation of photoacoustic-ultrasonic (PAUS) imaging biomarkers for oxygen saturation (SO2) and perfusion to the treatment response from sorafenib in an orthotopic rat model of HCC.

Original languageEnglish (US)
Title of host publication2017 IEEE International Ultrasonics Symposium, IUS 2017
PublisherIEEE Computer Society
ISBN (Electronic)9781538633830
DOIs
StatePublished - Oct 31 2017
Event2017 IEEE International Ultrasonics Symposium, IUS 2017 - Washington, United States
Duration: Sep 6 2017Sep 9 2017

Publication series

NameIEEE International Ultrasonics Symposium, IUS
Volume0
ISSN (Print)1948-5719
ISSN (Electronic)1948-5727

Other

Other2017 IEEE International Ultrasonics Symposium, IUS 2017
Country/TerritoryUnited States
CityWashington
Period9/6/179/9/17

ASJC Scopus subject areas

  • Acoustics and Ultrasonics

Fingerprint

Dive into the research topics of 'Notice of Removal: Photoacoustic-ultrasonic imaging biomarkers for treatment-response assessment of sorafenib in a rat model of hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this